Concentric Capital Strategies’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$697K Buy
11,265
+6,539
+138% +$353K 0.04% 255
2026
Q1
$256K Sell
4,726
-62,970
-93% -$4.13M 0.02% 291
2025
Q4
$4.16M Buy
67,696
+36,212
+115% +$2.34M 0.2% 110
2025
Q3
$2.3M Buy
+31,484
New +$2.48M 0.1% 164
2024
Q3
Sell
-24,531
Closed -$2.28M 282
2024
Q2
$2.28M Buy
+24,531
New +$2.6M 0.11% 184

Other funds holding BXC

Concentric Capital Strategies's BXC Position: Q2 2026 in Review

Concentric Capital Strategies increased its BlueLinx (BXC) stake by 138% in Q2 2026, buying an estimated $353K and bringing the position to 11,265 shares worth $697K. The position accounts for 0.04% of the portfolio, ranked #255.

Concentric Capital Strategies first reported a position in BXC in Q2 2024 and has held it in 5 quarters since. The position peaked at $4.16M in Q4 2025. 158 funds tracked by Wall St. Rank hold BXC as of Q2 2026.

  • Concentric Capital Strategies held 11,265 shares of BlueLinx worth $697K as of Q2 2026.
  • Concentric Capital Strategies bought 6,539 BlueLinx shares in Q2 2026, an estimated $353K.
  • BlueLinx made up 0.04% of Concentric Capital Strategies's portfolio in Q2 2026, its #255 holding.
  • Concentric Capital Strategies first reported a position in BlueLinx in Q2 2024 and has held it in 5 quarters since.
  • Concentric Capital Strategies's BlueLinx position peaked at $4.16M in Q4 2025.
  • 158 funds tracked by Wall St. Rank held BlueLinx as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.